Xtant Medical
-
Biologics
curasan Inc. announces Orthopedic Private Label Distribution Agreement
Kleinostheim, Germany / Research Triangle Park, NC, USA, November 2, 2017 – curasan Inc., the US-subsidiary of curasan AG (ISIN…
Read More » -
Xtant Medical Enters into a Distribution Agreement with curasan, Inc. Bringing Matriform™ to Market
BELGRADE, Mont., Nov. 01, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of…
Read More » -
Biologics
Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility
BELGRADE, Mont., Oct. 06, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of…
Read More » -
Hospitals
Xtant Medical Receives 510k Clearance for Expanded Indications of Irix-A
BELGRADE, Mont., Sept. 12, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of…
Read More » -
Hospitals
Xtant Medical Receives FDA Clearance for Calix-C Cervical Interbody Line Extension and Expanded Indications
BELGRADE, Mont., Aug. 09, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American:XTNT), a leader in the development of…
Read More » -
Financial
Xtant Medical to Announce Second Quarter 2017 Results on August 9th, 2017
BELGRADE, Mont., July 24, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Spine
Xtant Medical Enters into Licensing Agreement for Sites Medical’s OsteoSync Ti Technology
BELGRADE, Mont., May 16, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Financial
Xtant Medical Announces OrbiMed Financing and Engagement of Aurora Management Partners
BELGRADE, Mont., May 12, 2017 (GLOBE NEWSWIRE) — Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Financial
Xtant™ Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period
BELGRADE, Mont., May 09, 2017 (GLOBE NEWSWIRE) — Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Biologics
Xtant Medical Recognized as Montana Ambassador Business of the Year
BELGRADE, Mont., April 25, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Financial
Xtant™ Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period
March 09, 2017 Fourth Quarter 2016 Highlights: Consolidated total revenue increased 9.9% to a record $24.5 million compared to fourth…
Read More » -
Xtant Medical Announces the Operations Expansion of Montana’s Tissue Processing Rooms
BELGRADE, Mont., July 26, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Spine
Xtant™ Medical Receives CE Mark for Its Aranax™ Cervical Plating System and Irix-A™ Stand Alone Anterior Lumbar Interbody Fusion Device
BELGRADE, Mont., March 03, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Spine
Xtant™ Medical Announces First Surgical Case of Atrix-C™ Cervical Allograft Interbody Spacer
BELGRADE, Mont., Dec. 09, 2015 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Spine
Xtant™ Medical Announces the Global Launch for the Certex® OCT Spinal Fixation System
BELGRADE, Mont., Dec. 08, 2015 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative…
Read More »